Skip to main content
. 2016 Aug 9;7(37):60461–60474. doi: 10.18632/oncotarget.11124

Figure 2. Phenotype of 4T1 TDLN B cells.

Figure 2

A. The purity of 4T1 TDLN B cells. TDLN cells were double stained with anti-CD3 and anti-CD19 before and after CD19+ cell purification. B. Detection of IL-2R (CD25) on the cell surface of purified 4T1 TDLN B cells. B cells were double stained with anti-CD19 and anti-CD25 antibodies before and after B cell activation and expansion (A/E). Results are shown in two independent experiments performed. C. 4T1 TDLN B cell activation and expansion (A/E) significantly augmented IL-2R(CD25)-expressing B cells.